Publication

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women

The article titled "Using PBPK modeling to supplement clinical data and support the safe and…

Certara2024 年 10 月 30 日

Publication

Impact of Milk pH and Fat Content on the Prediction of Milk-to-Plasma Ratio

Explore how milk pH and fat content influence drug milk-to-plasma ratio predictions and inform lactation…

Certara2024 年 10 月 25 日

Conference

16th Annual World ADC London 2026

Certara2024 年 10 月 11 日

Publication

A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk

The article, authored by Caroline Sychterz, Hong Shen, Yueping Zhang, Michael Sinz, Amin Rostami-Hodjegan, Brian…

Certara2024 年 9 月 18 日

Publication

A tutorial on PBPK approaches in lactation research

Learn how physiologically based pharmacokinetic modeling can support drug transfer and infant exposure predictions during…

Certara2024 年 9 月 16 日

Publication

A tutorial on physiologically based pharmacokinetic approaches in lactation research

The tutorial by Amita Pansari, Xian Pan, Lisa M. Almond, and Karen Rowland-Yeo examines the…

Certara2024 年 9 月 16 日

Publication

美国 FDA 批准的新型药物应用基于生理的药代动力学模型应用

The article from the European Journal of Pharmaceutical Sciences reviews the role of Physiologically Based…

Certara2024 年 9 月 1 日

Publication

预测涉及抑制作用的 CYP 介导的 DDIs：满足 Simcyp Simulator 系统鉴定要求的方法

The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…

Certara2024 年 8 月 26 日

Publication

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…

Certara2024 年 8 月 26 日

Video

Certara 在 MIDD 领域的肿瘤学解决能力

Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…

Certara2024 年 8 月 7 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

模型引导的药物开发

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women

Impact of Milk pH and Fat Content on the Prediction of Milk-to-Plasma Ratio

16th Annual World ADC London 2026

A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk

A tutorial on PBPK approaches in lactation research

A tutorial on physiologically based pharmacokinetic approaches in lactation research

美国 FDA 批准的新型药物应用基于生理的药代动力学模型应用

预测涉及抑制作用的 CYP 介导的 DDIs：满足 Simcyp Simulator 系统鉴定要求的方法

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

Certara 在 MIDD 领域的肿瘤学解决能力

订阅时事通讯

快捷链接

解决方案

联系我们